Research output per year
Research output per year
Search results
-
2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma
d'Ancona, G., Kavanagh, J. E., Dhariwal, J., Hearn, A. P., Roxas, C., Fernandes, M., Green, L., Thomson, L., Nanzer, A. M., Jackson, D. J. & Kent, B. D., Jul 2021, In: Allergy: European Journal of Allergy and Clinical Immunology. 76, 7, p. 2238-2241 4 p.Research output: Contribution to journal › Letter › peer-review
20 Citations (Scopus) -
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy
Hearn, A. P., Hug, O. D., Somani, Z. A., Kavanagh, J., d'Ancona, G., Roxas, C., Green, L., Thomson, L., Fernandes, M., Kent, B. D., Dhariwal, J., Nanzer, A. M. & Jackson, D. J., 1 Jun 2021, In: The European respiratory journal. 57, 6, 2100166.Research output: Contribution to journal › Letter › peer-review
Open Access3 Citations (Scopus) -
Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
Kavanagh, J. E., Hearn, A. P., Dhariwal, J., d'Ancona, G., Douiri, A., Roxas, C., Fernandes, M., Green, L., Thomson, L., Nanzer, A. M., Kent, B. D. & Jackson, D. J., Feb 2021, In: Chest. 159, 2, p. 496-506Research output: Contribution to journal › Article › peer-review
205 Citations (Scopus) -
The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
Hearn, A. P., Kavanagh, J., d'Ancona, G., Roxas, C., Green, L., Thomson, L., Fernandes, M., Kent, B. D., Dhariwal, J., Nanzer, A. M. & Jackson, D. J., May 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 5, p. 2093-2096.e1Research output: Contribution to journal › Article › peer-review
54 Citations (Scopus) -
2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Kent, B. D., d'Ancona, G., Fernandes, M., Green, L., Roxas, C., Thomson, L., Nanzer, A. M., Kavanagh, J., Agarwal, S. & Jackson, D. J., Jan 2020, In: ERJ Open Research. 6, 1Research output: Contribution to journal › Article › peer-review
Open Access29 Citations (Scopus) -
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma
Kavanagh, J. E., Grainne, D., Elstad, M., Green, L., Fernandes, M., Thomson, L., Roxas, C., Dhariwal, J., Nanzer, A. M., Kent, B. D. & Jackson, D. J., Aug 2020, In: Chest. 158, 2, p. 491-500 10 p.Research output: Contribution to journal › Article › peer-review
160 Citations (Scopus) -
2019
Chronic cough and gastroesophageal reflux in children: Chest guideline and expert panel report
CHEST Expert Cough Panel, 1 Jan 2019, In: Annals of the rheumatic diseases. 78, 3, p. 131-140 10 p.Research output: Contribution to journal › Article › peer-review
33 Citations (Scopus) -
Over- and under-diagnosis in asthma
Kavanagh, J., Jackson, D. J. & Kent, B. D., Mar 2019, In: Breathe. 15, 1, p. e20-e27Research output: Contribution to journal › Review article › peer-review
Open Access98 Citations (Scopus) -
Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma
Jackson, D., Roxas, C., Thompson, L., Fernandes, M., Green, L., Kavanagh, J., Nanzer-Kelly, A., D'Ancona, G. & Kent, B., 28 Sept 2019, In: European Respiratory Journal. 54Research output: Contribution to journal › Meeting Abstract › peer-review
-
The relationship between severe asthma eosinophilic phenotypes and the clinical response to benralizumab at 16 weeks
Jackson, D., Roxas, C., Green, L., Fernandes, M., Thompson, L., Kavanagh, J., D'Ancona, G., Nanzer-Kelly, A. & Kent, B., 28 Sept 2019, In: European Respiratory Journal. 54Research output: Contribution to journal › Meeting Abstract › peer-review
-
2018
Sleep and asthma
Kavanagh, J., Jackson, D. J. & Kent, B. D., Nov 2018, In: Current Opinion in Pulmonary Medicine. 24, 6, p. 569-573Research output: Contribution to journal › Review article › peer-review
63 Citations (Scopus)